WO2011008111A1 - Preparation for regeneration of postoperative, post-traumatic bone defects and method for implantation of this preparation - Google Patents
Preparation for regeneration of postoperative, post-traumatic bone defects and method for implantation of this preparation Download PDFInfo
- Publication number
- WO2011008111A1 WO2011008111A1 PCT/PL2009/000075 PL2009000075W WO2011008111A1 WO 2011008111 A1 WO2011008111 A1 WO 2011008111A1 PL 2009000075 W PL2009000075 W PL 2009000075W WO 2011008111 A1 WO2011008111 A1 WO 2011008111A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- preparation
- favourably
- amount
- weight
- amounts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/12—Phosphorus-containing materials, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/10—Ceramics or glasses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3608—Bone, e.g. demineralised bone matrix [DBM], bone powder
Definitions
- the subject of the invention is a preparation for regeneration of postoperative and post-traumatic bone defects and method for implantation of this preparation, employed in many branches of medicine especially in orthopedics, dental surgery, reconstructive surgery, periodenthology and implantology.
- xenogeneic grafts or implants e.g. compositions of horse bone and cattle bone create a risk of transmission of animal diseases, e.g. BSE (Bovine Spongiform Encephalopathy).
- BSE Bovine Spongiform Encephalopathy
- pathogenic micro-organisms There is also a potential risk of transmission of pathogenic micro-organisms.
- the objective of this invention is creating a new therapeutically effective preparation for regeneration bone defects, which will show low biotoxicity and small systematic side effects at surgical application.
- This invention helps to fulfill the above task.
- the preparation components have been marked with letters A, B, C, TCP.
- the essence of this preparation is application of a deproteinized human bone (A), deprived of the smallest molecules of protein, with granulation from 0,3 to 0,5mm, bioglass (B) with granulation from 0,3 to 0,5mm and binder (C) favourably in the form of a patient's own blood in the amount of 20-25% in relation to the quantitative sum of the above components.
- A human bone
- tissue bank in the form of hydroxyapatite, with appropriate granulation, as well as in the form of trochlea.
- the second component of the preparation bioglass (B), in the form of powder with granulation 0,3-0, 5mm, can be obtained with use of zol-gel method in the system CaO-SiCh-PiOs.
- This component can also be used as a high silica component (80% mol. SiOa) or/and as a high calcium component (54% mol. CaO).
- TCP tricalcium phosphate
- This invention enables a faster regeneration of human bone tissue defects arising from intended activities, such as surgical activities, or unintended activities - injuries and disease process.
- Application of the above preparation results in a fast and complete regeneration of anatomic profile and physiological function.
- This invention helps to speed up the process of regeneration of damaged bone, and it contributes to compensation of biodegradation during the process of healing, due to active surfaces of the applied filler.
- an appropriate amount of the preparation is being mixed with binder i.e. the blood from operative wound (the mixture should be homogeneous).
- binder i.e. the blood from operative wound
- the mixture which has consistency of Plasticine
- the obtained mixture which has consistency of Plasticine, is implanted into bone defects.
- Application of a patient's own blood enriches the implanted preparation with organic components, e.g. collagen type 1, proteins, polysaccharides, lipids, necessary for osteogenesis and for preventing the preparation components from moving inside the operative wound.
- the components contained in a regenerating bone amount to 25% of the bone's weight.
- the components enumerated above, especially collagen increase bone's resistance to mechanical destruction caused by tension that occurs during work, and reduce brittleness of bones. More over collagen and protein fibers accelerate crystallization of hydroxyapatite.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ceramic Engineering (AREA)
- Materials For Medical Uses (AREA)
Abstract
According to the invention preparation for regeneration of bone defects is employed in many branches of medicine, especially in orthopedics, dental surgery, reconstructive surgery, periodonthology and implantology. The preparation has been developed on the basis of inorganic chemical compound naturally occurring, i.e. deproteinized human bone, and on the basis of at least one of inorganic chemical compounds synthetically occurring, i.e. bioglass in the form of granulated highcalcium product (54% mol. CaO), obtained with the use of zol-gel method in the system CaO-SiO2-P2O5, of density 2,9082 g/cm3, with phase composition with a dominant glassy phase and beginnings of crystallization of apatite, heat treated at temperature of 800°C, having a specific surface BET 57,8166 m2/g and/or tricalcium phosphate - TCP in the form of granulated product with chemical formula Ca3 (PO4)2. As a component deproteinized particlesof human bone are used, favourably with granulation 0,3-0,5 mm, bioglass favourably with granulation 0,3-0,5 mm and/or TCP — tricalcium phosphate favourably with granulation 0,3-0,5 mm. The amount of bone material in the preparation amounts favourably to 70-80% of the preparation weight, the amount of bioglass in preparation amounts favourably to 10-15% of the preparation weight, the amount of TCP in the preparation amounts favourably to 10-15% of the preparation weight. During implantation binder in the form of blood from patient's operative wound is introduced into the preparation. Amount of the preparation in mixture favourably amounts to 75-80% of the mixture weight and the amount of own blood favourably amounts to 20-25% of the mixture weight.
Description
PREPARATION FOR REGENERATION OF POSTOPERATIVE, POST-TRAUMATIC BONE
DEFECTS AND METHOD FOR IMPLANTATION OF THIS PREPARATION
The subject of the invention is a preparation for regeneration of postoperative and post-traumatic bone defects and method for implantation of this preparation, employed in many branches of medicine especially in orthopedics, dental surgery, reconstructive surgery, periodenthology and implantology.
Nowadays popularly applied xenogeneic grafts or implants e.g. compositions of horse bone and cattle bone create a risk of transmission of animal diseases, e.g. BSE (Bovine Spongiform Encephalopathy). There is also a potential risk of transmission of pathogenic micro-organisms.
There are also autogenic bone implants of patient's own bone, most often taken from oral cavity area. Bone can also be collected from other patient's anatomic areas, but it cannot be done in a dentist's office. Most often such surgery is performed in a clinic.
The objective of this invention is creating a new therapeutically effective preparation for regeneration bone defects, which will show low biotoxicity and small systematic side effects at surgical application.
This invention helps to fulfill the above task. For purposes of clarity the preparation components have been marked with letters A, B, C, TCP. The essence of this preparation is application of a deproteinized human bone (A), deprived of the smallest molecules of protein, with granulation from 0,3 to 0,5mm, bioglass (B) with granulation from 0,3 to 0,5mm and binder (C) favourably in the form of a patient's own blood in the amount of 20-25% in relation to the quantitative sum of the above components. For making this preparation one could use human bone (A) available in tissue bank in the form of hydroxyapatite, with appropriate granulation, as well as in the form of trochlea. The second component of the preparation bioglass (B), in the form of powder with granulation 0,3-0, 5mm, can be obtained with use of zol-gel method in the system CaO-SiCh-PiOs. This component can also be used as a high silica component (80% mol. SiOa) or/and as a high calcium component (54% mol. CaO). High silica component of a density 2,4037 g/cm3, heat treated at temperature of 700 0C, amorphous, has a specific surface BET 297, 9663m2/g. Whereas high calcium component of a density 2,9082 g/cm3, with phase composition with a dominant glassy phase and beginnings of crystallization of apatite, heat treated at temperature of 800°C, has a
specific surface BET 57,8166 m2/g. This kind of bioactive glass of preparation spontenaously forms union with maternity tissue and stimulates regeneration of bone tissue. Under "in vivo" conditions on the surface of biomaterial hydroxyapatite layer (HAp) crystallizes with chemical and mineralogical composition similar to bone HAp (natural). In this way an exceptionally durable chemical bond (bonding interface) is formed. In a living organism in the presence of bioglass numerous biochemical and biological processes take place, e.g. proteins adsorption, synchronized cells occurrences which result in a quick forming of administered bone tissue. The invention also anticipates that instead of bioglass (B), a tricalcium phosphate (TCP) could be applied - favourably with granulation 0,3-0,5mm, in the amount of 15-20% of the preparation weight.
Unexpectedly it has also turned out that it in possible to get very good therapeutic results in regeneration of bone defects, by compiling all the above mentioned components of the preparation. As components are simultaneously used deproteinized preparation of bone (A) with granulation 0,3 -0,5mm in the amount favourably 70-80% of the preparation weight, bioglass (B) in the form of granulated product in the amount favourably 10-15% of the preparation weight, tricalcium phosphate TCP favourably 10-15% of the preparation weight, and binder (C) favourably in the amount of 20-25% of the preparation weight in relation to the quantitative sum of the amount of the above components.
Particular components are mixed in strictly defined proportions and strictly defined granulation. There are several reasons why it should be done this way. The main reason is atrophy of bone structure during spontaneous healing of wounds that reaches 20-30% of volume. Application of deproteinized human bone supplements natural hydroxyapatite in a wound, TCP slows down the process of atrophy and in this way reduces biodegradation, whereas bioglass due to its biologically active surface stimulates osteogenesis and functions as space filler when not being subjected to biodegradation.
This invention enables a faster regeneration of human bone tissue defects arising from intended activities, such as surgical activities, or unintended activities - injuries and disease process. Application of the above preparation results in a fast and complete regeneration of anatomic profile and physiological function. This invention helps to speed up the process of regeneration of damaged bone, and it contributes to compensation of biodegradation during the process of healing, due to active surfaces of the applied filler.
According to this invention an appropriate amount of the preparation is being mixed with binder i.e. the blood from operative wound (the mixture should be homogeneous). The obtained mixture which has consistency of Plasticine, is implanted into bone defects.
Application of a patient's own blood enriches the implanted preparation with organic components, e.g. collagen type 1, proteins, polysaccharides, lipids, necessary for osteogenesis and for preventing the preparation components from moving inside the operative wound. The components contained in a regenerating bone amount to 25% of the bone's weight. The components enumerated above, especially collagen, increase bone's resistance to mechanical destruction caused by tension that occurs during work, and reduce brittleness of bones. More over collagen and protein fibers accelerate crystallization of hydroxyapatite.
Claims
1. Preparation for regeneration of postoperative and post-traumatic bone defects based on inorganic chemical compound naturally occurring and synthetically occurring, is characterized by the fact that the said preparation contains as its component particles of deproteinized human bone (A) favourably with granulation from 0,3 to 0,5mm, bioglass (B) in the form of granulated product and binder (C), and the amount of bone material in the preparation amounts favourably to 80-85% of the preparation weight, bioglass favourably 15-20% of the preparation weight, and binder 20-25% of the preparation weight in relation to the sum of amounts of the above components.
2. According to the claim 1, the preparation is characterized by the fact, that bioglass (B) is obtained with use of zol-gel method in the system CaO-SiCh-PzOs as high silica material (80% mol Siθ2) or as a high calcium material (54% mol CaO).
3. According to the claim 1, the preparation is characterized by the fact, that a patient's own blood is favourably used as binder (C).
4. According to the claim 1 , the preparation is characterized by the fact that instead of bioglass (B) a tricalcium phosphate marked below as component TCP is applied, favourably with granulation 0,3 -0,5mm, and the amount of bone material (A) in the preparation amounts favourably to 80-85% of the preparation weight, and TCP favourably 15-20% of the preparation weight.
5. According to claims 1-4 the preparation is characterized by the fact that the following materials are applied as components: bone material (A) with granulation 0,3-0, 5mm favourably in the amount 70-80% of the preparation weight, bioglass (B) in the granulated product in the amount favourably 10-15% of the preparation weight, tricalcium phosphate TCP favourably in the amount 10-15% of the preparation weight and binder (C) favourably in the amount 20-25% of the preparation weight in relation to the sum of the amount of the bone components.
6. The manner of implantation of the preparation for regeneration of postoperative and post-traumatic bone defects is characterized by the fact that during operation an appropriate amount of the preparation is mixed with binder, i.e. the blood from operative wound (the mixture should be homogenous). The obtained mixture, which has consistency of Plasticine, is implanted into bone defects, and the amount of the preparation in the mixture favourably amounts to 75-80% of the mixture weight, and the amount of blood in the mixture favourably amounts to 20-25% of the mixture weight.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/PL2009/000075 WO2011008111A1 (en) | 2009-07-17 | 2009-07-17 | Preparation for regeneration of postoperative, post-traumatic bone defects and method for implantation of this preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/PL2009/000075 WO2011008111A1 (en) | 2009-07-17 | 2009-07-17 | Preparation for regeneration of postoperative, post-traumatic bone defects and method for implantation of this preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2011008111A1 true WO2011008111A1 (en) | 2011-01-20 |
Family
ID=41796418
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/PL2009/000075 Ceased WO2011008111A1 (en) | 2009-07-17 | 2009-07-17 | Preparation for regeneration of postoperative, post-traumatic bone defects and method for implantation of this preparation |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2011008111A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021247348A1 (en) * | 2020-06-01 | 2021-12-09 | Bone Solutions, Inc. | Bio-material composition and methods of use |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0577342A1 (en) * | 1992-06-29 | 1994-01-05 | Queen Mary And Westfield College | Sintered hydroxyapatite compositions and method for the preparation thereof |
| WO1998040113A1 (en) * | 1997-03-13 | 1998-09-17 | University Of Florida Tissue Bank, Inc. | Bone paste |
| US6235225B1 (en) * | 1999-08-10 | 2001-05-22 | Ngk Spark Plug Co., Ltd. | Process for producing biocompatible implant material |
| WO2007084609A2 (en) * | 2006-01-19 | 2007-07-26 | Osteotech, Inc. | Porous osteoimplant |
| EP2080528A1 (en) * | 2008-01-17 | 2009-07-22 | Tadeusz Cieslik | Preparation for regeneration of post-operative and post-traumatic bone defects and method for implantation of this preparation |
-
2009
- 2009-07-17 WO PCT/PL2009/000075 patent/WO2011008111A1/en not_active Ceased
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0577342A1 (en) * | 1992-06-29 | 1994-01-05 | Queen Mary And Westfield College | Sintered hydroxyapatite compositions and method for the preparation thereof |
| WO1998040113A1 (en) * | 1997-03-13 | 1998-09-17 | University Of Florida Tissue Bank, Inc. | Bone paste |
| US6235225B1 (en) * | 1999-08-10 | 2001-05-22 | Ngk Spark Plug Co., Ltd. | Process for producing biocompatible implant material |
| WO2007084609A2 (en) * | 2006-01-19 | 2007-07-26 | Osteotech, Inc. | Porous osteoimplant |
| EP2080528A1 (en) * | 2008-01-17 | 2009-07-22 | Tadeusz Cieslik | Preparation for regeneration of post-operative and post-traumatic bone defects and method for implantation of this preparation |
| US20090186063A1 (en) * | 2008-01-17 | 2009-07-23 | Tadeusz Cieslik | Preparation for regeneration of postoperative, post-traumatic bone defects and method for implantation of this preparation |
Non-Patent Citations (2)
| Title |
|---|
| BERGMAN S A ET AL: "BONE IN-FILL OF NON-HEALING CALVARIAL DEFECTS USING PARTICULATE BIOGLASS AND AUTOGENOUS BONE", BIOCERAMICS, XX, XX, 1 January 1995 (1995-01-01), pages 17 - 24, XP000869797 * |
| HANKER J S ET AL: "SETTING OF COMPOSITE HYDROXYLAPATITE/PLASTER IMPLANTS WITH BLOOD FOR BONE RECONSTRUCTION", PROCEEDINGS OF THE ANNUAL MEETING OF THE ELECTRON MICROSCOPYSOCIETY OF AMERICA, XX, XX, vol. 22, 1 January 1986 (1986-01-01), pages 328/329, XP009025391 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021247348A1 (en) * | 2020-06-01 | 2021-12-09 | Bone Solutions, Inc. | Bio-material composition and methods of use |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8303971B2 (en) | Preparation for regeneration of postoperative, post-traumatic bone defects and method for implantation of this preparation | |
| US6117456A (en) | Methods and products related to the physical conversion of reactive amorphous calcium phosphate | |
| AU2005286719B2 (en) | Multi-purpose bio-material composition | |
| Fernandes et al. | Calcium sulfate as a scaffold for bone tissue engineering: a descriptive review | |
| Jazayeri et al. | Dental applications of natural‐origin polymers in hard and soft tissue engineering | |
| Al‐allaq et al. | A review: In vivo studies of bioceramics as bone substitute materials | |
| Lodoso-Torrecilla et al. | Bioinorganic supplementation of calcium phosphate-based bone substitutes to improve in vivo performance: a systematic review and meta-analysis of animal studies | |
| Lun et al. | Limitations and modifications in the clinical application of calcium sulfate | |
| Ana | Bone substituting materials in dental implantology | |
| Baino | Ceramics for bone replacement: Commercial products and clinical use | |
| Yassine et al. | Repair of segmental radial defect with autologous bone marrow aspirate and hydroxyapatite in rabbit radius: A clinical and radiographic evaluation | |
| Elshahat et al. | The use of Novabone and Norian in cranioplasty: A comparative study | |
| CA2748642C (en) | Enhanced medical implant | |
| Kirschner et al. | Repair of the immature craniofacial skeleton with a calcium phosphate cement: quantitative assessment of craniofacial growth | |
| Cutter et al. | Bone grafts and substitutes | |
| Pagani et al. | Update on synthetic biomaterials combined with fibrin derivatives for regenerative medicine: Applications in bone defect treatment: Systematic review | |
| Mehrvar et al. | In vivo analysis of a proprietary glass-based adhesive for sternal fixation and stabilization using rabbit and sheep models | |
| WO2006076426A2 (en) | Multi-purpose bio-material composition | |
| WO2003049780A1 (en) | Biocompatible composite material with an osteotropic action | |
| Harsini et al. | Bone grafting and the materials for using in orthopaedics | |
| McPherson et al. | Bone grafting with coralline hydroxyapatite | |
| WO2011008111A1 (en) | Preparation for regeneration of postoperative, post-traumatic bone defects and method for implantation of this preparation | |
| Komlev et al. | Bioactivity and effect of bone formation for octacalcium phosphate ceramics | |
| WO2017101021A1 (en) | Modified bone repairing material | |
| Mohan et al. | Current implants used in cranioplasty |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09788410 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 09788410 Country of ref document: EP Kind code of ref document: A1 |